Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-γ but not B cells, CD8+ T cells, or perforin

AIDS Research and Human Retroviruses

Volumn 26, Issue 7, 2010, Pages 783-793

  Surman, Sherri L ^a   Brown, Scott A ^a   Jones, Bart G ^a   Woodland, David L ^b   Hurwitz, Julia L ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b TRUDEAU INSTITUTE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENDAI VIRUS; TH1 CELL; TH2 CELL; UPREGULATION; VACCINATION; VIRUS RECOMBINANT; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; KNOCKOUT MOUSE;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENETIC VECTORS; HIV INFECTIONS; HIV-1; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERFORIN; SENDAI VIRUS;

EID: 77954903715     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0266     Document Type: Article

References (56)

1. MacLennan IC, Liu YJ, and Johnson GD: Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immunol Rev 1992;126:143-161.
2. Chan WL, Lukig ML, and Liew FY: Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. J Exp Med 1985;162(4):1304-1318.
3. Williams MA, Holmes BJ, Sun JC, and Bevan MJ: Developing and maintaining protective CD8\+ memory T cells. Immunol Rev 2006;211:146-153.
4. Clark EA and Ledbetter JA: How B and T cells talk to each other. Nature 1994;367(6462):425-428.
5. Brown SA, Hurwitz JL, Zirkel A, et al.: A recombinant Sen-dai virus is controlled by CD4\+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein. J Virol 2007;81(22):12535-12542.
6. Christensen JP, Cardin RD, Branum KC, and Doherty PC: CD4(\+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci USA 1999;96(9):5135-5140.
7. Andreansky S, Liu H, Adler H, et al.: The limits of protection by "memory" T cells in Ig-/-mice persistently infected with a gamma-herpesvirus. Proc Natl Acad Sci USA 2004;101(7): 2017-2022.
8. Brown SA, Stambas J, Zhan X, et al.: Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in activity. J Immunol 2003;171(8):4140-4148.
9. Surman S, Lockey TD, Slobod KS, et al.: Localization of CD4\+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci USA 2001;98:4587-4592.
10. Brown SA, Lockey TD, Slaughter C, et al.: T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spec-trometry. Aids Res Hum Retroviruses 2005;21(2):165-170.
11. Jellison ER, Kim SK, and Welsh RM: Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 2005;174(2):614-618.
12. Nikiforow S, Bottomly K, Miller G, and Munz C: Cytolytic CD4(\+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 2003;77(22):12088-12104.
13. Brown DM, Dilzer AM, Meents DL, and Swain SL: CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 2006;177(5):2888-2898.
14. Brown DM, Kamperschroer C, Dilzer AM, Roberts DM, and Swain SL: IL-2 and antigen dose differentially regulate per-forin-and FasL-mediated cytolytic activity in antigen specific CD4\+ T cells. Cell Immunol 2009;257(1-2):69-79.
15. Casazza JP, Betts MR, Price DA, et al.: Acquisition of direct antiviral effector functions by CMV-specific CD4\+ T lymphocytes with cellular maturation. J Exp Med 2006;203(13): 2865-2877.
16. Tay SS, McCormack A, Lawson C, and Rose ML: IFN-gamma reverses the stop signal allowing migration of antigen-specific T cells into inflammatory sites. J Immunol 2003;170(6):3315-3322.
17. Mikloska Z, Kesson AM, Penfold ME, and Cunningham AL: Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J Infect Dis 1996;173(1):7-17.
18. Berman JS, Beer DJ, Theodore AC, et al.: Lymphocyte recruitment to the lung. Am Rev Respir Dis 1990;142(1):238-257.
19. Kato A, Sakai Y, Shioda T, et al.: Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1996;1(6):569-579.
20. Sakai Y, Kiyotani K, Fukumura M, et al.: Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication. FEBS Lett 1999;456(2):221-226.
21. Takimoto T, Hurwitz JL, Coleclough C, et al.: Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. J Virol 2004;78(11):6043-6047.
22. Hou S, Doherty PC, Zijlstra M, Jaenisch R, and Katz JM: Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8\+ T cells. J Immunol 1992;149:1319-1325.
23. Sarmiento M, Glasebrook AL, and Fitch FW: IgG and IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T-cell mediated cytolysis in the absence of complement. J Immunol 1980;125:2665-2672.
24. Mahy BWJ and Kangro HO: Virology Methods Manual. San Diego, CA, 1996.
25. Lehner T, Tao L, and Panagiotidi C, et al.: Mucosal model of genital immunization in male rhesus macaques with a re-combinant simian immunodeficiency virus p27 antigen. J Virol 1994;68:1624.
26. Belyakov IM, Hel Z, Kelsall B, et al.: Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 2001;7(12): 1320-1326.
27. Belyakov IM, Derby MA, Ahlers JD, et al.: Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci USA 1998;95:1709-1714.
28. Bogers WM, Bergmeier LA, Ma J, et al.: A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 2004;18(1):25-36.
29. Zhong W, Marshall D, Coleclough C, and Woodland DL: CD4\+ T cell priming accelerates the clearance of Sendai virus in mice, but has a negative effect on CD8\+ T cell memory. J Immunol 2000;164(6):3274-3282.
30. Zhong W, Roberts AD, and Woodland DL: Antibody-independent antiviral function of memory CD4\+ T cells in vivo requires regulatory signals from CD8\+ effector T cells. J Immunol 2001;167(3):1379-1386.
31. Ostler T, Davidson W, and Ehl S: Virus clearance and im-munopathology by CD8(\+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur J Immunol 2002;32(8):2117-2123.
32. de Alencar BC, Persechini PM, Haolla FA, et al.: Perforin and interferon-{gamma} expression are required for CD4\+ and CD8\+ T cell-dependent protective immunity against a human parasite (Trypanosoma cruzi) elicited by a heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun 2009;77(10):4383-4395.
33. Castilow EM, Meyerholz DK, and Varga SM: IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 2008; 180(4):2376-2384.
34. McGill J, Heusel JW, and Legge KL: Innate immune control and regulation of influenza virus infections. J Leukoc Biol 2009;86:803-812.
35. Hildeman D and Janssen E: IFN-gamma and self-absorbed CD4\+ T cells: A regulatory double negative. Nat Immunol 2008;9(11):1210-1212.
36. Zamai L, Ahmad M, Bennett IM, et al.: Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;188(12):2375-2380.
37. Karupiah G, Chen JH, Nathan CF, Mahalingam S, and MacMicking JD: Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J Virol 1998;72(9):7703-7706.
38. Bogdan C, Rollinghoff M, and Diefenbach A: Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000;12(1):64-76.
39. MacLean A, Wei XQ, Huang FP, et al.: Mice lacking induc-ible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol 1998;79(Pt 4):825-830.
40. Walzer T, Jaeger S, Chaix J, and Vivier E: Natural killer cells: From CD3(-)NKp46(\+) to post-genomics meta-analyses. Curr Opin Immunol 2007;19(3):365-372.
41. Wesa AK and Storkus WJ: Killer dendritic cells: Mechanisms of action and therapeutic implications for cancer. Cell Death Differ 2008;15(1):51-57.
42. Junt T, Moseman EA, Iannacone M, et al.: Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007;450(7166):110-114.
43. Schoenborn JR and Wilson CB: Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101.
44. Hardy AW, Graham DR, Shearer GM, and Herbeuval JP: HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci USA 2007;104(44):17453-17458.
45. Talloczy Z, Virgin HW, and Levine B: PKR-dependent au-tophagic degradation of herpes simplex virus type 1. Au-tophagy 2006;2(1):24-29.
46. Herold S, Steinmueller M, et al.: Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008;205(13):3065-3077.
47. Wurzer WJ, Ehrhardt C, Pleschka S, et al.: NF-kappaB-dependent induction of tumor necrosis factor-related apo-ptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem 2004; 279(30):30931-30937.
48. Chaperot L, Blum A, Manches O, et al.: Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasma-cytoid dendritic cells. J Immunol 2006;176(1):248-255.
49. Lee HK, Lund JM, Ramanathan B, Mizushima N, and Iwasaki A: Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007;315(5817):1398-1401.
50. Rosenberg HF, Dyer KD, and Domachowske JB: Respiratory viruses and eosinophils: Exploring the connections. Antiviral Res 2009;83(1):1-9.
51. Appay V, Zaunders JJ, Papagno L, et al.: Characterization of CD4(\+) CTLs ex vivo. J Immunol 2002;168(11):5954-5958.
52. Slobod KS and Allan JE: Parainfluenza type 1 virus-infected cells are killed by both CD8\+ and CD4\+ cytotoxic T cell precursors. Clin Exp Immunol 1993;93:363-369.
53. Kaur G, Tuen M, Virland D, et al.: Antigen stimulation induces HIV envelope gp120-specific CD4(\+) T cells to secrete CCR5 ligands and suppress HIV infection. Virology 2007; 369(1):214-225.
54. Abdelwahab SF, Cocchi F, Bagley KC, et al.: HIV-1-suppressive factors are secreted by CD4\+ T cells during primary immune responses. Proc Natl Acad Sci USA 2003;100(25):15006-15010.
55. Hardy GA, Sieg SF, Rodriguez B, et al.: Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood 2009; 113(22):5497-5505.
56. Levy JA, Scott I, and Mackewicz C: Protection from HIV/AIDS: The importance of innate immunity. Clin Immunol 2003;108(3):167-174.